The world’s first solution to eliminate all mosquito-borne diseases
The mosquito is the deadliest animal on the planet. It kills nearly 1 million people every year by transmitting illnesses such as malaria, zika, dengue fever, but there has been no significant progress in reducing malaria cases in the world.
The world's first ultra-effective mosquito-only phagostimulant (HMBPP). A novel, sustainable, and cost-effective way to fight against these small, yet deadly, foes by identifying and isolating natural compounds that target mosquitoes and modify their behavior. Unlike other solutions on the market, the product solely targets mosquitoes to feed on a natural toxin without affecting other species.
Lech Ignatowicz, PhD: CEO
Lech is an entrepreneur with over 15 years in infectious disease prevention and commercialization background. He holds a PhD in Medical Science from Karolinska Institutet as well as BSc in Biotechnology and MSc in Microbiology from Warsaw University.
Noushin Emami, PhD: CSO
Noushin is a scientist in the field of vector diseases, with over 15 years of mosquito and malaria research. She is currently an Associate Professor at Stockholm University.
Johan Paleovrachas, Chairman of the Board.
Johan is a management entrepreneur with experiences in land and property development in Sweden and Africa with over 20 years business experience.